Interferon alfacon1 is an inhibitor of SARS-corona virus in cell-based models

Preliminary data examining interferon alfacon1 treatment of SARS-CoV (severe acute respiratory syndrome-corona virus)-infected patients suggests this therapy is well tolerated and of therapeutic benefit. We report herein that interferon alfacon1, has potent in vitro antiviral activity against SARS-C...

Descripción completa

Detalles Bibliográficos
Autores principales: Paragas, Jason, Blatt, Lawrence M., Hartmann, Chris, Huggins, John W., Endy, Tim P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2005
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114208/
https://www.ncbi.nlm.nih.gov/pubmed/15911026
http://dx.doi.org/10.1016/j.antiviral.2005.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7114208/
https://www.ncbi.nlm.nih.gov/pubmed/15911026
http://dx.doi.org/10.1016/j.antiviral.2005.01.002

Ejemplares similares